Intuitive Surgical reported quarterly revenue of $2.87 billion, up 18.8% year-over-year, driven by placements of 325 new da Vinci surgical systems globally. The company posted adjusted EPS of $2.53, beating consensus by $0.26 and marking a 14.5% increase over the same quarter last year. Systems sales grew 22%, while parts and services revenue expanded 17%, underscoring the recurring-revenue model that now represents 65% of total revenue. Management reiterated its long-term target of mid-teens revenue growth, citing continued uptake in oncology and urology procedures.

Alpha Cubed Investments LLC increased its Intuitive Surgical stake by 13.0% during Q3, acquiring an additional 10,677 shares to reach 92,600 shares valued at $41.4 million. Valley Wealth Managers lifted its position by 52.7% to 4,084 shares, while Strategic Advisors added 4,031 shares for a total holding of 10,397 shares. Together, these moves pushed institutional ownership to 83.6% of outstanding common stock. Active growth managers like Polen Capital have highlighted ISRG as a core holding, signaling conviction in the company’s multi-year growth trajectory.

The FDA expanded the da Vinci 5 indication set to include select advanced cardiac procedures, opening an estimated $800 million addressable market for system installations and consumables over the next five years. Following this approval, TD Cowen upgraded coverage to strong-buy, and Barclays reaffirmed its buy rating, while HSBC issued a bullish target citing a favorable reimbursement environment. Evercore ISI trimmed its near-term price forecast but maintained an outperform rating, reflecting mixed views on valuation versus sustained margin expansion.

Over the last 90 days, corporate insiders have sold a combined 75,557 shares worth approximately $42 million, led by director Gary S. Guthart’s disclosed sale of 27,300 shares. SVP Mark Brosius and EVP Henry L. Charlton reduced their holdings by 83% and 81.8%, respectively, following transactions that totaled over $10 million. Despite these dispositions, insider ownership remains under 1%, and the company reaffirmed its commitment to share-repurchase authorization of $6 billion through year-end to support capital return strategies.